
Market Insight | AK MEDICAL plunges more than 17%, major downgrade in medical device Q2 performance expectations, company to release earnings by the end of this month

AK MEDICAL's stock price plummeted by over 17% today, with the latest price at HKD 3.58 and a turnover of HKD 51.013 million. Goldman Sachs expects the medical device industry's performance in the second quarter to be weak, lowering the target price and sales forecast for the fiscal years 2024 to 2025. The market is concerned about the impact of changes in medical policies. Despite facing challenges, Ping An Securities believes that AK MEDICAL, as a leading company in the orthopedic joint field, will benefit from the aging trend and is expected to maintain steady growth in the future. The company will release its interim performance on the 28th of this month
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

